ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Reminyl®/- Prolonged Release:Janssen-Cilag AG
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
Registration ownerLast update of information 

Galenische Form und Wirkstoffmenge pro Einheit

Filmtablette zu 4 mg (weiss): Galantamini Hydrobromid. 5,127 mg (corresp. Galantamin. 4 mg). Filmtablette zu 8 mg (rosa): Galantamini Hydrobromid. 10,254 mg (corresp. Galantamin. 8 mg). Filmtablette zu 12 mg (orange-braun): Galantamini Hydrobromid. 15,380 mg (corresp. Galantamin. 12 mg).
Prolonged Release Kapseln zu 8 mg (weiss): Galantamini Hydrobromid. 10,25 mg (corresp. Galantamin. 8 mg).
Prolonged Release Kapseln zu 16 mg (rosa): Galantamini Hydrobromid. 20,51 mg (corresp. Galantamin. 16 mg).
Prolonged Release Kapseln zu 24 mg (karamell-farbig): Galantamini Hydrobromid. 30,76 mg (corresp. Galantamin. 24 mg).

2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home